Pharma Marketing Talk


Follow This Show

Stay in the know about new episodes and updates.
Interviews of leaders and innovators in pharmaceutical marketing.

Upcoming Broadcasts

Will New FDA Guidelines Allow Pharma to Join In? Pharmaguy interviews Peter Kirk, CEO & Sermo, who talks about the nature and value of physician discussions on Sermo and how pharma can engage docs on social media sites and online discussion boards. Questions/Topics of Discussion Tell us a bit about Sermo and the physician members. Are physician members engaged in meaningful discussions on Sermo? What are they discussing? Jeff Tangney, CEO of Doximity, said most online physician discussions were mundane and not related to medical practice. In the past Sermo has worked with pharma companies such as Pfizer to bring them into these discussions (see here). How did that work? Was it successful? What kinds of discussions do physicians on Sermo want to have with pharma? In your opinion, what impact will the recent FDA guidelines have on how the pharmaceutical industry engages physicians on social media sites and discussion boards such as Sermo. What value can pharma marketers gain from engaging in physician discussions via social media? What values can physicians gain?
Reminder Edit Reminder

On-Demand Episodes

To date, efforts by regulators and the generic industry to combat Authorized Generics have been largely unsuccessful. With the new Democratic-controlled Congress and a federal budget increasingly burdened by pharmaceutical... more

The new Customer Manages Relationship marketing strategy is one way that pharma marketers can create a new beginning with patients and phsyicians. Alfred O'Neill of Ryan TrueHealth explains how.

An interview with Cary Byrd, founder of, an online Rx search site and blog.

An interview with Fard Johnmar, founder of Envision Solutions, a healthcare marketing communications consultancy, and creator of the HealthcareVOX blog.

An interview with Jim Edwards, Senior Editor, Brandweek, who just started his own blog: BrandweekNRX. Will blogging corrupt journalists or vice versa?

I interview Jay Silverstein, the COO of Revolution Health, about its new health portal web site. I am particularly interested in the "social networking" aspect of the site where users can rate products and post comments. Will pharmaceutical... more

The return on investments for traditional pharma marketing channels -- TV, drug reps, print -- is declining. Increase marketing ROI using "social networking" and other Web 2.0 technologies.

Disease mongering is a term used to describe a perceived attempt by pharmaceutical companies to promote public awareness of (frequently harmless) conditions or diseases with the aim of increasing sales of medication.Guests:... more

A Pharma Marketing Roundtable discussion devoted to likely new legislation.

John Mack interviews industry speakers live at the eyeforpharma e-Communication and Online Marketing conference